Attached files
| file | filename |
|---|---|
| EX-3.2 - EX-3.2 - Luckwel Pharmaceuticals Inc. | ex3-2.htm |
| EX-3.1 - EX-3..1 - Luckwel Pharmaceuticals Inc. | ex3-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 3, 2017 (March 30, 2017)
LUCKYCOM PHARMACEUTICALS INC.
(Exact name of registrant as specified in its charter)
|
Nevada
|
333-187874
|
46-1660653
|
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
11767 Katy Freeway, Suite 830, Houston, Texas 77079
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, include area code 281-668-8266
1790 Hughes Landing Blvd. Suite 400, The Woodlands, Texas 77380
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K fi ling is intended to simultaneously satisfy the fi ling obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
The Board of Directors of Luckycom Pharmaceuticals Inc., formerly known as Luckycom Inc. (the “Company “) approved a change in the Company’s name from “Luckycom Inc.” to “Luckycom Pharmaceuticals Inc.”
The change in the Company’s name was effected by the filing of an Amendment to Articles of Organization (the “Amendment”) pursuant to NRS 86.221 on March 30, 2017. Pursuant to this Amendment, Article 1. of the Company’s Amended and Restated Certificate of Incorporation was amended to read in its entirety as follows:
“1: Name of Corporation: LUCKYCOM PHARMACEUTICALS INC.”
The Company also amended and restated its by-laws to reflect the new corporate name.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
|
Exhibit No.
|
Description
|
|
|
3.1
|
||
|
3.2
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| LUCKYCOM, INC. | |||
|
Date: April 3, 2017
|
By:
|
/s/ Kingrich Lee | |
| Name: Kingrich Lee | |||
|
Chief Executive Officer and Chief Financial Officer
|
|||